Article
Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.
Diagnostic microbiology and infectious disease - 1 Feb 2000
Hadziyannis E, Tuohy M, Thomas L, Procop G W, Washington J A, Hall G S
Abstract excerpt
Escherichia coli and Klebsiella spp. were screened for ESBL based on routine susceptibility testing results. Isolates with intermediate or resistant susceptibilities for extended spectrum cephalosporins or aztreonam were reported as probable ESBL producers. By using the NCCLS proposed ESBL confirmatory method, we tested 61 screen-positive isolates from 42 patients, 30 randomly selected susceptible isolates, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
